ArticleDiagnostics (Basel, Switzerland)2022

Serum Growth Differentiation Factor-15/Albumin Ratio as a 2-Year Survival Marker of End-Stage Renal Disease Patients Initiating Maintenance Hemodialysis.

Eu-Jin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.